Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccinal Activity Assessment of MenBVac Against Neisseria Meningitidis B:14,P1.7,16 Strain in Child
NCT01621945Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Apr 2012
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of MenBvac in meningococcal disease, sponsored by Rouen University Hospital. Primary endpoint: Vaccine Immunity at 1 year. Started Apr 2012; status: completed.
02
Drugs
MenBvac
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT01621945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01621945.